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Abstract
Background: Type-I interferons, type-II interferons, and the IL-10 family are helical cytokines with similar three-dimensional
folds. However, their homologous relationship is difficult to detect on the basis of sequence alone. We have previously
described the discovery of the human type-III interferons (IFN lambda-1, -2, -3 or IL-29, IL-28A, IL-28B), which required a
combination of manual and computational techniques applied to predicted protein sequences.
Principal Findings: Here we describe how the use of gene structure analysis and comparative genomics enabled a more
extensive understanding of these genes early in the discovery process. More recently, additional mammalian genome
sequences have shown that there are between one and potentially nine copies of interferon lambda genes in each genome,
and that several species have single exon versions of the interferon lambda gene.
Significance: The variable number of single exon type-I interferons in mammals, along with recently identified genes in
zebrafish homologous to interferons allows a story of interferon evolution to be proposed. This model suggests that the
gene duplications and single exon retrotransposons of mammalian type-III interferons are positively selected for within a
genome. These characteristics are also shared with the fish interferons and could be responsible for the generation of the
IL10 family and also the single exon type-I interferons.
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Introduction
The use of sequence similarity between proteins to infer a
functional relationship helped to define the beginnings of
bioinformatics. Algorithms that rapidly compare large volumes
of protein or DNA sequences have often been used to explore
evolutionary relationships between genes and between organisms
(e.g. BLAST [1]). Concurrently, the richness and complexity of the
genome has motivated study of the non-coding regions, including:
chromosome rearrangement, transcription factor binding sites,
repetitive and transposable elements, exon-intron gene structure,
comparative genomics and genetic variation, among others. The
study of non-coding regions has allowed the development of
additional approaches to identify evolutionary relationships
between genes.
Many groups have pursued the identification and functional
annotation of novel mammalian helical cytokines (interleukins and
interferons) based on protein sequence similarity. However, helical
cytokines are notoriously hard to detect based on protein sequence
alone because their three-dimensional fold is particularly permis-
sive to sequence perturbation [2]. This makes distantly homolo-
gous sequences difficult to distinguish from non-homologous
sequences of similar amino acid content. A quasi-threading
approach was developed to specifically recognize the protein
sequence for members of this family [3,4]. Later developments to
this technique include using a combination of protein similarity
and exon-intron gene structure to characterize many diverse
members of the helical cytokine family [5], and to identify
evolutionary subclasses within this family. However, these
techniques still generate many false positives which lead to
expensive efforts to try to validate the computational discovery
in the wet lab. Therefore, we have used a combination of protein
sequence and genomics based methods to focus our lab efforts on
good candidate cytokines and drop wasted efforts on the false
positives.
Several years ago, we and our colleagues discovered a novel
helical cytokine that we first described in a patent application
entitled ‘‘Interferon Like Protein’’ [6]. Later, we described two
other proteins that were members of the same ligand family
(initially referred to as the IL28 family), whose members were
designated IL29 (the protein in ref. [6]), IL28A, and IL28B by
HUGO and a heterodimeric class II cytokine receptor for all three
proteins, IL10-RB/IL28Ra [7]. Simultaneously, Kotenko et. al.
[8] described the same receptor (which they designated IFN-lR1),
and demonstrated that the protein described in ref. [6] was a
ligand for this receptor. They also described the other two
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interferon l1 (the protein in ref. [6]), l2 and l3 (HUGO aliases:
IFNL1, IFNL2, IFNL3). Both of these papers [7,8] also described
the signaling activity of the ligands and the expression pattern of
the receptor.
These genes have recently been classified as type-III interferons
by the Nomenclature Committee of the International Society for
Interferon and Cytokine Research, and the lambda nomenclature
will be used here. Protein sequence similarity shows that the
interferon lambda family is approximately equidistant between
type-I interferons and the IL10 cytokine family. One receptor
subunit is shared between the heterodimeric receptors for
interferon lambda and IL10, and there is commonality in the
gene structures of the interferon lambda and IL10 families.
Because the type-III interferons show anti-viral activity
[6,7,8,9,10,11,12], and the distribution of their receptor complex
is distinct from the type-I IFN receptor [7,8,13], interferon lambda
has the potential for in vivo anti-viral activity with fewer side-effects
than interferon alpha. ZymoGenetics is currently conducting
clinical trials of PEGylated IFNL1 for the treatment of chronic
Hepatitis C infection.
Previously [7], we provided a brief description of how we
discovered this gene family. Specifically, we compiled a set of
appropriately sized (140–200 residues), potentially secreted
proteins [14] from human gene predictions [15], and with no
readily detectable sequence similarity to other known genes.
Families of similar proteins within this smaller set were found, and
the helical cytokine quasi-threading method [4] and manual
protein alignments allowed this novel cytokine family to be
identified. In this paper, we will describe the genomic data that
provided further evidence for interferon-lambda membership in
the helical cytokine family. The more recent availability of many
mammalian genomes has allowed us to identify members of the
interferon-lambda family; the diversity of these family members
has some interesting parallels with the type-I interferon family.
The parent gene of the interferon lambda gene family may be the
same parent gene which gave rise to the type-I interferons and the
IL10 family. The discovery and annotation of the interferon-
lambda family is a case where many pieces of bioinformatics
analysis built upon each other to discover a very exciting new sub-
family within the drug and target rich family of helical cytokines.
Analysis
Protein Sequence
The similarity between any of the human interferon lambda
proteins to any other helical cytokine or interferon is below the
detection limit for BLAST [16], even using a very permissive p-
value threshold. A manual sequence alignment reveals that the
specific percent identity between the interferon lambda family and
other helical cytokine families is approximately 5% (to type-II
interferon), 12% (to type-I interferons), and 15% (to IL10 family
members). This weak similarity and the corresponding lack of
BLAST detection is consistent with the relationships between the
type-I interferons, type-II interferon and the IL10 families, i.e. the
inter-family percent identity between any of these families is
between 5 and 12%. Within the human interferon lambda family,
the percent identity is between 81% and 96%, with IFNL2 and
IFNL3 being the most closely related.
Given the inability to detect any similarity using BLAST, other
methods were required for discovery. Using the quasi-threading
technique [4], proteins can be given a score based on how
compatible their sequence is with the helical cytokine fold. At the
time of its discovery [6,7], the human interferon-lambda family
members scored at a level such that approximately 400 proteins
from human REFSEQ score as well as this family, yet only about
13% of these higher scoring proteins are known helical cytokines.
Furthermore, 10% of the helical cytokines known at the time of
discovery had a lower score than the interferon lambda family. As
described in Sheppard et. al. [7], a multiple sequence alignment of
interferon lambdas with IL10 and type-I interferons increased our
confidence in the quasi-threading score because it showed that the
amphipathic helices, flexible loops and some cysteine locations
appeared to be consistent between type-III interferons and the
other helical cytokines.
Exon-intron structure
The type-III interferon family has a multi-exon gene structure
(Figure 1) in which there are five conserved exons and an initial
exon which is observed in IFNL2 and IFNL3 but not IFNL1.
However, the original gene predictions for human IFNL2 and
IFNL3, produced by GENSCAN [15], contained only five exons.
The cloned cDNA sequence of human IFNL2 and IFNL3 mRNA
revealed an unpredicted upstream exon (exon 1’), as shown in
Figure 1 and reported earlier [7]. This exon contains a short
coding region of only four amino acids, which includes the codon
for the initiating Met. As opposed to the other introns in this gene
which are all phase zero, the intron after exon 1’ splits a codon
such that one nucleotide of the codon triplet resides on exon 1’. All
other exon boundaries between IFNL2 and IFNL3 are in the same
positions as those in IFNL1. Interestingly, a multi-exon interferon
from zebrafish has a differentially expressed transcript with an
alternate splice event at the 59 end in which an additional exon
eliminates the secretion signal [17]. In summary, the human genes
in the type-III interferon family have five conserved exons, but
there is an additional 59 exon in IFNL2 and IFNL3 which codes
for a few amino acids, including the initial Met.
Gene family evolution: genomic organization and species
conservation
In the completed mammalian genomes of human and mouse,
the type-III interferon genes are organized in a single gene cluster
and in a very similar pattern [18]. The gene ordering in human
(chr 19q13) and mouse (chr 7A3) is nearly identical and has been
described [18], where the nomenclature has been established as
follows: interferon-lamba-1, interferon-lamba-2, interferon-lamba-
Figure 1. Gene structure of human IFNL1, IFNL2 and IFNL3. Each numbered box represents an exon (not drawn to scale). The shorter
extensions at the terminal exons represent noncoding DNA. The letters inside the boxes are protein structural features: (S)ecretion peptide, helix (A),
helix (B), helix (C) and helix (D).
doi:10.1371/journal.pone.0004933.g001
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strand, and the second pair on the forward strand. However,
interferon-lambda-1 is a pseudogene in mouse, while interferon-
lambda-4 is a pseudogene in both species [18] (experimental
cloning of human IFNL4 was attempted in our company and
several spliced transcripts were found in various tissues [data not
shown]; however, 59 RACE experiments did not reveal an ORF
with a Met, which led us to conclude that human IFNL4 is a
pseudogene). In both human and mouse, approximately 6 kilo-
bases (kb) of DNA at gene loci for IFNL2 and IFNL3 have
nucleotide sequence identity greater than 97% for the whole
genomic region (including exons, introns and ,1 kb flanking
DNA). In both genomes, these two gene loci are inverted with
respect to each other and have about 10 kb of intervening DNA
[18]. When human IFNL2 and IFNL3 are compared to IFNL1,
only the coding and regulatory regions share any significant DNA
similarity.
We used the human members of the interferon lambda family to
query most of the completed and draft genomes in the ENSEMBL
database (version 49, March 2008) using BLAST. Full length or
unique fragments of type-III interferon family members were
found in 23 of 24 of the mammalian species and in chicken, but
not in the 7 other eukaryotic species that we checked (Table 1).
Specifically, we used tblastn (protein query and DNA database)
with the default search parameters (word size=3, BLOSUM62
matrix, gap insertion/extension=9/2, using the ENSEMBL
Table 1. Number and gene structure of Interferon Lambda genes in many genomes from ensembl v49.
Species (brief name)
Maximum number of multi-
exon gene loci [a] (and
chromosomal location, if
known)
Number of single exon
gene loci (and
chromosomal location,
if known)
Number of nearly
full length genes
(and pseudogene,
if confirmed)
genome sequence
version (in ENSEMBL 49)
Armadillo - - - ARMA
Bat 5* 2 1 MICROBAT1
Bush baby 1 - - BUSHBABY1
Cat 4* 1 3 CAT
Chimp 4 (c19) - 1 CHIMP2.1
Cow - 1* (c13) 1 Btau_3.1
Dog 2 (c1) 1 (c24) 3 BROADD2
Elephant 2 - - BROADE1
Guinea pig 3 - 1 GUINEAPIG
Hedgehog 5 - - HEDGEHOG
Horse 3* (c22) 1 (c10) 3 EquCab2
Human 4 (19q13) - 3 (1) NCBI36
Lemur 3 - - micMur1
Mouse 3 (7A3) - 2 (1) NCBIM37
Opossum 2 (c4, c3) - - BROADO5
Orangutan 6 (c19) - 1 PPYG2
Pika 5* - - pika
Platypus 3 - - OANA5
Rabbit 2 - - RABBIT
Rat 4 (c1, c17) - 1 RGSC3.4
Rhesus 6* (c19) - 1 MMUL_1
Shrew 9 - 5 COMMON_SHREW1
Squirrel 2* - - SQUIRREL
Tree shrew 2 - 1 TREESHREW
Chicken 1 (c7) - - WASHUC2
Frog - - - JGI4.1
Fugu - - - FUGU4
Zebra fish - - - ZFISH7
C elegans - - - WS180
Fly - - - BDGP5.4
Mosquito - - - AgamP3
Yeast - - - SGD1.1
[a]To be consistent, this total includes genes and pseudogenes. For draft genomes, not finding all exons in a short contig due to assembly and sequencing gaps is
indistinguishable from a pseudogene with some exons missing.
*the noted species has one gene which needs a frameshift of 1 bp or 2 bp needed in order to stay in the ‘‘correct’’ reading frame. This frameshift might indicate that this
is a pseudogene, or it might be a sequencing error due to the draft nature of the genome sequence.
doi:10.1371/journal.pone.0004933.t001
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homologies’’ or ‘‘no optimisation’’ search) and found the
mammalian hits to have significance scores (P-values) better than
about 10E-9. For the multiple exon gene loci, we browsed the hits
and examined the ends of the putative exons and also manually
verified that the different hits within a single genome were distinct
sequences. There were a varying number of gene copies, with the
same exon pattern and/or full length single exon genes for each
species with type-III interferon genes. In all cases where interferon
lambda genes have multiple exons, the predicted exon boundaries
are conserved. One organism, the common shrew, has up to 9
distinct members of this family. However, since many of these
genomes are of draft quality, some of the gene hits which appear to
be different gene loci may actually be the same gene locus but
either have errors or are only partially sequenced. For example, in
the common shrew, 5 of the 9 possible gene loci were found on
contigs which are long enough to contain the full length sequence.
The 5 loci were very similar to each other, with about 97%
identity in the coding regions and 87% identity in the introns. For
the remaining 4 gene loci in common shrew, the contigs were
shorter and only contained one end of the coding region, which
implies that those 4 regions may be as few as 2 different genes with
the middle part of the gene not yet sequenced and assembled.
Furthermore, depending on the finished sequence, the gene loci
counts listed in Table 1 may include pseudogenes, since some of
the BLAST results showed that a frameshift would be necessary to
remain in the correct reading frame. To computationally predict if
any of these genes are expressed, we searched dbEST [19] using
BLAST and only found a handful of human ESTs and a single
EST from pig (EW341616). Overall, the mammals contain a wide
range in the number of copies of interferon lambda gene loci.
There were also many examples of type-III interferon genes
which are contained in a single coding exon. For example, in dog,
there were three type-III interferon family genes in which each
gene locus was fully contained on its own contig of draft genomic
sequence; but, none of the genes were on the same contig. One of
the dog genes was located on chromosome 24 and has a single
predicted exon (also see [20]), and the other two are multi-exon
genes which are neighbors of unknown distance and orientation
on chromosome 1. In dog, the single exon gene is 80% identical to
one of the multi-exon genes; whereas, the two multi-exon genes
are 70% identical to each other. In all species where the
chromosomal location is available for both types of genes, the
single exon genes are located on a different chromosome than the
multi-exon genes (Table 1), suggesting a retrotransposition event
for the gene duplication [21,22].
The most distant organism in which our BLAST queries of
human type-III interferon against the ENSEMBL genomes were
able to detect orthologs was chicken. Despite the fact that this
search did not find any hits in fish, frog or invertebrates, genes
coding for interferon family members have been identified in fish
[23,24,25,26,27]. These genes contain five exons and had been
originally grouped with the type-III interferons based on protein
similarity [23]. However, other analyses [28,20], and our own
sequence comparisons conclude that the amino acid sequences of
interferons from fish are considerably more similar to mammalian
type-I interferons. Thus, it appears that fish interferons have the
same multi-exon gene structure as mammalian type-III interfer-
ons, yet their protein sequence is more similar to type-I
interferons.
We generated a phylogenetic tree with the human, mouse, dog
and guinea pig genes, including the human and mouse
pseudogenes (Figure 2, and Supplementary Figure S1). The
reason we used a nucleotide alignment which included the
pseudogenes was so that we could determine the relative ages of
the pseudogenes. Due to the degeneracy of the genetic code, and
Figure 2. Phylogenetic tree using the actual or predicted DNA sequences of spliced interferon lambda genes or pseudogenes in
human, mouse, dog and guinea pig. Human and mouse gene loci are labeled as in Lasfar et. al. [18]. The labels for dog and guinea pig are not
intended to be suggestions for permanent names. The ‘‘dog1’’ gene is the single exon gene from dog on chromosome 24, while ‘‘dog2’’ and ‘‘dog3’’
are multi exon genes located near each other on chromosome 1 (see Supplementary Figure S1 for gene sequences). The sequence for the more
distant mouse pseudogene, named interferon lambda 4 in Lasfar et. al., was excluded because we were unable to find the locus. The optimal tree is
drawn to scale, with bootstrap values shown at branch points and branch lengths in the same units as those of the evolutionary distances used to
infer the phylogenetic tree (sum of branch length=1.0194). All positions containing gaps and missing data were eliminated from the dataset, and the
full codons were used. There were a total of 314 nucleotide positions in the final dataset, compared to the longest sequence of 622 nucleotides (the
pseudogenes shortened the total number of columns which were available for alignment).
doi:10.1371/journal.pone.0004933.g002
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rates for each type of nucleotide, there are more detailed
theoretical models of estimating evolutionary distances with
nucleotide sequences than with protein sequences. The tree was
made using the neighbor-joining method [29] in MEGA4 [30]
with evolutionary distances estimated by Tamura-Nei [31]. In an
effort to better estimate the robustness of the trees which were
generated, bootstrapping [32] was also performed (N=1000), in
which variants of the input alignment are used to create trees
which are compared to the initial tree. The Tamura-Nei distance
was chosen for Figure 2 because it is a popular method; however,
the tree structure and bootstrap values were very robust and did
not change appreciably as different distance measures were used,
or as the codon positions used in the distance were varied. In the
resulting tree for interferon lambda in human, mouse, dog and
guinea pig, the bootstrap values indicate that the mouse and
human genes and pseudogenes are reliably separate from each
other.
Discussion
Due to the sequence diversity of the helical cytokine fold, the
type-III interferons are very difficult to detect as homologs using
standard bioinformatics tools. As reported earlier [7], only the
combined use of specialized software to detect a helical cytokine
fold [4], other protein sequence filters (length, secretion signal,
sequence clustering into a novel family), and manual knowledge-
based multiple sequence alignments, allowed us to identify these
family members as novel helical cytokines. However, even these
methods generate false positives, and, we used additional methods
based on genomic information to add confidence to our
assignment of sequences to the helical cytokine family. The use
of genomic, non-coding sequence information to further annotate
a gene is an important method in gene discovery, especially when
protein similarity methods begin to reach their limit.
The chromosomal locations, exon-intron gene structure and
promoter analysis can be used to validate evolutionary relation-
ships between helical cytokines and infer function. For example, in
the IL10 family of cytokines, four genes (IL10, IL19, IL20 and
IL24) are located in a cluster at human 1q32, and the other two
IL10 family members (IL22 and IL26) are located at 12q15 (with
IFNG nearby) [5]. The human type-III interferon gene family is
also located in its own chromosomal cluster (19q13). Furthermore,
all six of the IL10 family genes, along with IL3, IL21 and IFNL1
(IL29) have the identical five exon gene structure in which intron
locations divide the alpha helices in analogous positions and no
codons are split by introns [5]. Lastly, the promoter of IFNL2 and
IFNL3 contains potential immune-related transcription factor
binding sites [33]; however, these regulatory regions are not
conserved in ancient fish [34]. These genomic insights, along with
the species conservation, helped increase our confidence in the
importance of the type-III interferon family as functionally
important helical cytokines.
In this paper, we show that the 5-exon INFL1 and 6-exon
INFL2/3 are very similar to the 5-exon IL10 gene family. As we
previously reported [7], INFL2 and IFNL3 have a starting exon
with a very short coding region (exon 1’), while the remainder of
the introns have the same intron phase and position as IFNL1 and
all the members of the IL10 family. In addition, there is evidence
in the mouse genome for a potential exon with a splice donor
about 100 bp upstream which contains an ATG and two other
amino acids in the correct frame (data not shown). Sequences of
human IFNL2 and IFNL3 cDNAs were published [8] which do
not contain exon 1’; and, similarly, the published sequences of
mouse type-III interferons [18] also lack this intron. However,
both of those studies used PCR to clone interferon lambda family
members from genomic DNA starting at the predicted secretion
cleavage site, followed by cloning the spliced mRNA from
mammalian cells. Thus, for human IFNL2 and IFNL3, there is
no evidence for a transcript which omits exon 1’. Other
mammalian mRNA needs to be characterized in order to
determine the extent of the presence of exon 1’. It is unclear
whether the five- or six- exon version of interferon lambda was
present in the rodent-primate ancestor.
Given the desire to make animal model data relevant to
humans, we made an effort to determine a probable orthology
assignment between the interferon lambda genes in human and
mouse. One common bioinformatics approach to determine
orthology involves comparing the detailed ordering of related
genes on a chromosomal locus between species. Since the
interferon lambda gene organization between human and mouse
appears so similar, this is the approach that was used to assign the
names of the mouse genes in Lasfar et. al. [18]. This approach to
orthology assignment assumes that the ancestral species of mouse
and human also had a similar gene organization which was
conserved for nearly 100 million years and is still present today.
However, a phylogenetic tree using the DNA sequences for the
human, mouse, dog and guinea pig genes (Figure 2) shows that the
primate-rodent speciation event occurred before the multiple gene
loci duplicated and diverged from each other. Given this tree
(Figure 2), the most parsimonious interpretation is that all current
interferon lambda genes arose from a single interferon lambda
gene in an ancestral species. Another possibility is that the human-
mouse ancestor had four genes arranged like it is observed in
humans and that a recent gene conversion event (in both human
and mouse) caused all of the genes to appear more closely related.
Regardless, the observation that human and mouse have a nearly
identical gene ordering requires a recent coincidence in either
gene duplication or gene conversion, as it is unlikely that the
present day genes are the direct product of a gene duplication or
conversion event from a multiple gene cluster in the human-mouse
ancestor. Due to the widely varying number of type-III interferon
genes in mammalian species, and the observation that in several
species these genes are most closely related to others in their same
genome, the simplest explanation is all these genes are derived
from a single gene in the mammalian ancestor.
With respect to biological function, gene expression patterns
and the role of genomic duplication, it is unclear how to interpret
the significance of the similar human and mouse gene ordering
and the variation in gene count between mammals. Multiple
copies of genes allow for higher RNA expression under a greater
number of conditions and also for divergence of function. Single
exon gene variants, usually the product of a retrotransposition
event, are smaller than their multi-exon counterparts which may
allow for more frequent and higher fidelity duplication. The order
and orientation of genes in compact genomes such as viruses and
bacteria can also have large effects on their expression patterns; so,
perhaps the similar gene ordering in human and mouse represents
some sort of optimum for regulating the expression levels [35,36].
In an analysis of copy number variants (CNV) and gene
duplications throughout the human genome, a recent study [37]
has proposed that gene duplications such as CNV occur frequently
for all functional families of proteins, but that the duplication of
genes encoding environmental response proteins are positively
selected over time, as opposed to genes encoding proteins involved
in basic cellular processes, which are negatively selected for
duplication. We explored the ratios between the total number of
type-I interferons and type-III interferons in mammals and could
Interferon Lambda Evolution
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these genes; nor was there sufficiently clear information regarding
viral diversity across these organisms to speculate why some
mammals have a much larger repertoire of interferons than others.
The long-term persistence of duplicate copies of type-I and type-
III interferons is consistent with each of these protein families
having environmental-response biological roles.
The evolutionary origins of type-I and type-III interferons are
intertwined and both families probably originate from a single
interferon gene family present in ancient fish, with representation
in present-day fish. Only one family of interferons has been found
in present-day fish [17,27,28], and there are attempts to argue that
the these fish interferons should be classified as type-I interferons
or type-III interferons. However, since the fish interferons
represent the ancestor gene that gave rise to both families, it is
not entirely meaningful to attempt to classify the parent gene as
being more related to one child than another. Because of this
parental relationship, the interferon in fish has been called
interferon-phi [38]. There is much evidence of shared ancestry,
since the protein sequence of the fish interferons appears more
similar to the type-I interferons, while the multi-exon gene
structure is identical to the type-III interferons. Another
commonality between the fish interferons and the mammalian
type-I family is the cysteine pattern and presence of the conserved
CAWE motif [27] – which both differ from the mammalian type-
III interferons. One complementary method to determine if the
fish interferons are more like type-I or type-III interferons is to
identify and characterize the receptors. Levraud et. al. [17] found
the heterodimer receptor (zCRFB2 and zCRFB5) in zebrafish
which responds to zIFN, and they concluded that the receptors
were more like the mammalian interferon type-III receptor
complex. However, a more recent paper [27] noted that Levraud
et. al. only looked at one of the three potential fish interferon
genes. Furthermore, a review of class 2 cytokine evolution [20]
successfully predicted the heterodimer receptor (CRFB2 and
CRFB5) for zIFN, which they classify as a type-I interferon; and,
they further predict that a different pair may serve as an alternate
interferon receptor system Overall, the current data suggest the
fish interferon family is the evolutionary predecessor to both
mammalian interferon families (type-I and type-III), and has gene,
protein and biological similarities with each family.
A model of interferon evolution can be developed as follows
(also see [20,23]). Four hundred million years ago, fish contained a
single family of interferons. This fish interferon family had
multiple exons and its biological role was to respond to viral
infection. Different fish species had differing numbers of interferon
genes, but they were all closely related. We do not know if the
different interferons bound to different receptors or if any species
had single exon versions of this gene family. As mammals first
appeared about three hundred million years ago, the original
interferon family had a genetic event where the spliced RNA was
reincorporated into the genome as a retrotransposon. This new
single exon gene had the same DNA sequence as the parental
gene. Over time, this new family (type-I interferon) kept much of
the original function, as evidenced by its slow accumulation of
differences compared to the fish interferon family. However, as a
single exon gene, it was easily duplicated over time and modern
day mammals have a wide range of copies of type-I interferons,
perhaps to increase overall expression levels throughout many cell
types in the body. However, the original multi-exon gene family,
which also gave rise to the IL10 family of cytokines, diverged more
quickly from the ancestral gene and eventually became known as
type-III interferons. The type-III interferons maintained an
important biological role in anti-viral response, and copies arose
via gene locus duplication, and in some species, via retro-
transposons. Independent duplication events occurred even after
different mammalian species diverged. Some duplications in both
the type-I and type-III interferon gene families have lead to
inactive pseudogenes. For example, in humans, IFNL1 diverged
from the IFNL2/3 ancestor after the rodent/human divergence,
but long before the recent duplication event between IFNL2 and
IFNL3, in which the coding and non-coding regions of the gene
duplication are still evident. Present day mammals contain a wide
ranging number of copies of type-I and type-III interferons, with
the type-III interferons present as both multi-exon and single-exon
genes.
In this paper, we have shown the detailed genomic analysis that
we used for the initial annotation of these proteins. Further, the
recent availability of many draft mammalian genomes has allowed
us to notice many parallels in gene duplication and intron-less
reinsertion between the type-III interferons and the type-I
interferons. The interferon gene family in fish has similarities
with both of these mammalian families. The evolutionary story of
this dynamic gene family and its role in immunity from fish to
mammals is becoming increasingly clear.
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